VVT Med, Inc. (VVTM.V)
0.16
0.00 (0.00%)
CAD |
TSXV |
Nov 13, 16:00
VVT Med Enterprise Value : 13.25M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 13.25M |
| November 12, 2026 | 13.62M |
| November 11, 2026 | 12.53M |
| November 10, 2026 | 12.53M |
| November 09, 2026 | 12.53M |
| November 06, 2026 | 12.53M |
| November 05, 2026 | 12.53M |
| November 04, 2026 | 15.43M |
| November 03, 2026 | 15.43M |
| November 02, 2026 | 13.25M |
| October 30, 2026 | 15.80M |
| October 29, 2026 | 15.80M |
| October 28, 2026 | 15.80M |
| October 27, 2026 | 15.80M |
| October 26, 2026 | 15.80M |
| October 23, 2026 | 15.80M |
| October 22, 2026 | 15.80M |
| October 21, 2026 | 15.80M |
| October 20, 2026 | 15.80M |
| October 19, 2026 | 16.16M |
| October 16, 2026 | 16.16M |
| October 15, 2026 | 16.16M |
| October 14, 2026 | 16.16M |
| October 13, 2026 | 16.16M |
| October 09, 2026 | 16.16M |
| Date | Value |
|---|---|
| October 08, 2026 | 16.16M |
| October 07, 2026 | 16.16M |
| October 06, 2026 | 16.16M |
| October 05, 2026 | 16.16M |
| October 02, 2026 | 16.16M |
| October 01, 2026 | 16.16M |
| September 30, 2026 | 16.16M |
| September 29, 2026 | 16.16M |
| September 28, 2026 | 16.16M |
| September 25, 2026 | 16.16M |
| September 24, 2026 | 16.16M |
| September 23, 2026 | 16.16M |
| September 22, 2026 | 16.16M |
| September 21, 2026 | 16.16M |
| September 18, 2026 | 16.16M |
| September 17, 2026 | 16.16M |
| September 16, 2026 | 16.16M |
| September 15, 2026 | 15.43M |
| September 14, 2026 | 16.16M |
| September 11, 2026 | 15.43M |
| September 10, 2026 | 16.16M |
| September 09, 2026 | 16.16M |
| September 08, 2026 | 15.43M |
| September 04, 2026 | 16.16M |
| September 03, 2026 | 16.88M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| MedMira, Inc. | 41.84M |
| MedX Health Corp. | 21.79M |
| VentriPoint Diagnostics Ltd. | -- |
| Theralase Technologies, Inc. | 49.59M |
| Profound Medical Corp. | 351.35M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.7725M |
| Revenue (Quarterly) | 0.0457M |
| Total Expenses (Quarterly) | 0.8182M |
| EPS Diluted (Quarterly) | -0.0108 |
| Gross Profit Margin (Quarterly) | 45.51% |
| Profit Margin (Quarterly) | -1.69K% |
| Earnings Yield | -52.75% |
| Normalized Earnings Yield | -48.88 |